CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus
Author:
Funder
Israel Science Foundation
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference34 articles.
1. The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases;Roncarolo;Immunity,2018
2. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients;Blair;Immunity,2010
3. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer;DiLillo;Ann. N. Y. Acad. Sci.,2010
4. Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor β1 in human peripheral blood;Karim;Arch. Med. Sci.,2019
5. The complex association of FcγRIIb with autoimmune susceptibility;Verbeek;Front. Immunol.,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma;European Journal of Medical Research;2023-11-18
2. Semaphorin 3A influences neuronal processes that are altered in patients with autism spectrum disorder: Potential diagnostic and therapeutic implications;Neuroscience & Biobehavioral Reviews;2023-10
3. Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer;Trends in Molecular Medicine;2023-10
4. Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases;Frontiers in Pharmacology;2023-01-10
5. Semaphorins in immune cell function, inflammatory and infectious diseases;Current Research in Immunology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3